Status:
COMPLETED
Pneumoniae Epidemiology Study in China
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Pneumococcal Disease
Eligibility:
All Genders
Up to 60 years
Brief Summary
To determine the proportion of hospitalized pneumonia cases in children aged 60 months or less associated with vaccine-preventable Streptococcus pneumoniae serotypes (4, 6B, 9V, 14, 18C, 19F, 23F).
Detailed Description
Subjects meeting the eligibility criteria, including parental informed consent to collect clinical-epidemiological information, will have a deep respiratory aspirate specimen to determine the etiology...
Eligibility Criteria
Inclusion
- Age, 60 months or less
- Meets study criteria for clinical pneumonia
- All the examination are/can be done within (before or after) 72 hours to enrollment time
- Informed consent obtained from parent or guardian
Exclusion
- Received any pneumococcal vaccine in the past
- Current or underlying conditions that would pose a hazard in obtaining the deep respiratory aspirate (e.g., bleeding diathesis, severe respiratory compromise and others as determined by clinician) Aspirates may be obtained from patients who are intubated
- Any other medical condition that in the opinion of the clinician/investigator would pose a hazard to the child by participating in the study
- Children with recurrent pneumonia will enter into the study on only one occasion
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2008
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00471770
Start Date
February 1 2007
End Date
February 1 2008
Last Update
March 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tianjin, China, 300074